Business Context and Reporting Period
This Form 8-K reports on the special meeting of stockholders held by Tharimmune, Inc. (trading symbol: THAR) on January 30, 2026. The filing was submitted on February 2, 2026. The company is incorporated in Delaware and lists its common stock on The Nasdaq Stock Market LLC. As of the record date (December 3, 2025), there were 36,444,785 shares of common stock outstanding.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
A quorum was established with 20,076,887 shares (approximately 55.08%) represented. All six proposals presented at the special meeting were approved by stockholders. Key outcomes include:
- Proposal 1 (Director Election): Jill E. Sommers and William Wiley were elected to the Board of Directors.
- Proposal 2 (Strategic Advisor Warrants): Approved the issuance of shares underlying outstanding Strategic Advisor Warrants.
- Proposal 3 (Cryptocurrency Warrants): Approved the issuance of shares upon exercise of Cryptocurrency Pre-Funded Warrants related to a private placement offering involving Canton Coin.
- Proposal 4 (Advisor RSUs): Approved the issuance of shares upon settlement of Advisor RSUs issued to the placement agent.
- Proposal 5 (Equity Plan Amendment): Approved an increase of 7,000,000 shares available for issuance under the Amended and Restated 2023 Omnibus Equity Incentive Plan.
- Proposal 6 (Adjournment Authority): Authorized adjournments to solicit additional proxies if necessary.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard disclosures inherent in the voting proposals. The primary event reported is the successful ratification of equity issuances and board changes.
Investor Verification Checklist
- Verify the dilution impact of the approved issuances under Proposals 2, 3, and 4 (Strategic Advisor Warrants, Cryptocurrency Warrants, and Advisor RSUs).
- Confirm the total share count increase resulting from the 7,000,000 share amendment to the Equity Incentive Plan (Proposal 5).
- Review the background and qualifications of the newly elected directors, Jill E. Sommers and William Wiley.
- Examine the terms of the "Canton Coin" private placement offering referenced in Proposal 3 to understand the valuation and consideration received.